Pyxis Oncology shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Pyxis Oncology (PYXS) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Pyxis Oncology
Tip: Access up to 7 years of quarterly data
All positions including Pyxis Oncology held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Pyxis Oncology by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $42k | 27k | 1.56 |
| 2024-09-30 | $81k | 22k | 3.67 |
| 2024-06-30 | $71k | 21k | 3.31 |
| 2024-03-31 | $2.1k | 500 | 4.26 |
| 2023-12-31 | $900 | 500 | 1.80 |
| 2023-09-30 | $995 | 500 | 1.99 |
| 2023-06-30 | $11k | 4.3k | 2.56 |
| 2023-03-31 | $20k | 5.0k | 3.97 |
| 2022-03-31 | $20k | 5.0k | 4.01 |
| 2021-12-31 | $130k | 12k | 11.02 |